- Woojin Trading distributes specialty beauty and personal care ingredients, backed by a technical team and in-house laboratory.
- The acquisition strengthens Brenntag's position in South Korea and creates a platform for growth across Beauty & Care and adjacent markets.
Brenntag [ISIN DE000A1DAHH0], the global market leader in chemicals and ingredients distribution, signed an agreement to acquire Woojin Trading Co., Ltd based in Anyang, South Korea.
The planned acquisition expands Brenntag's presence in South Korea's trend-setting beauty and personal care market. Combined customers will benefit from broader formulation expertise, in-house laboratory capabilities, and an expanded product portfolio.
Francois Bleger, Global President Brenntag Beauty & Care, commented: "The Korean market is a global trendsetter for beauty and personal care formulations and represents a significant growth opportunity. Mr. Song, Ms. Kim and the team at Woojin have built one of the leading distributors for specialty products and formulations in this market. Our strengthened footprint will serve as a bridgehead for accelerating Brenntag's other businesses across South Korea, and we are excited to combine our strengths to grow in Korea and beyond."
Founded in 1999 by Chairman Young Bae Song, Woojin has built a robust network of global suppliers alongside a rapidly expanding customer base across Asia and is one of the most reputable distributors of raw materials and ingredients for the beauty and personal care industry. The company has an in-house laboratory and deep, trusted partnerships with global supply partners.
Seon Yeon Kim, Chief Executive Officer of Woojin, commented: "We have built a strong foundation in South Korea, the hub of global beauty and personal care innovation. Joining Brenntag combines our regional expertise with global scale. Together, we can bring Korean beauty innovation to a global audience and unlock new growth for our team, customers, and partners."
Financial details are not being disclosed. Closing is subject to customary conditions, including third-party approvals, and is expected in Q4 2026.
